Researchers adjusted for confounders like age, hypertension, cardiovascular disease, and other comorbidities. The refined results indicated GLP-1 users had a 16% lower risk of developing epilepsy ...

A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...

Innovations such as nurse navigators, AI-assisted prior authorizations, and community education—including rural outreach—are ...

To help neurologists, mental health clinicians and other clinicians determine the best ways to help people manage functional seizures, the American Academy of Neurology has issued a new guideline, ...

People with impaired kidney function have higher levels of Alzheimer’s biomarkers in their blood, but not an increased risk of dementia, according to a study published December 3, 2025, in Neurology®, ...

A large study found that people with impaired kidneys tend to have higher Alzheimer’s biomarkers, yet they don’t face a ...

A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk ...

Popular GLP-1 medications such as Ozempic may carry an unexpected link to a lower risk of epilepsy in people with type 2 ...

People hospitalized for a debilitating migraine should receive targeted nerve blocks rather than IV opioids, new treatment ...

A sudden sensation of numbness? The nagging headache that just won't quit? That weird weakness in your leg? They're all ...

Kidney health may not raise dementia risk, but it can shift how fast dementia symptoms appear in those already vulnerable.

Researchers at Beijing Tiantan Hospital analyzed 101 glioma cases involving the brain’s motor pathway and found that ...